vs

Side-by-side financial comparison of Clearfield, Inc. (CLFD) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $28.9M, roughly 1.2× Outset Medical, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -67.5%, a 65.7% gap on every dollar of revenue. On growth, Outset Medical, Inc. posted the faster year-over-year revenue change (-2.0% vs -3.2%). Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-9.7M). Over the past eight quarters, Outset Medical, Inc.'s revenue compounded faster (1.2% CAGR vs -3.5%).

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

CLFD vs OM — Head-to-Head

Bigger by revenue
CLFD
CLFD
1.2× larger
CLFD
$34.3M
$28.9M
OM
Growing faster (revenue YoY)
OM
OM
+1.2% gap
OM
-2.0%
-3.2%
CLFD
Higher net margin
CLFD
CLFD
65.7% more per $
CLFD
-1.8%
-67.5%
OM
More free cash flow
CLFD
CLFD
$7.3M more FCF
CLFD
$-2.4M
$-9.7M
OM
Faster 2-yr revenue CAGR
OM
OM
Annualised
OM
1.2%
-3.5%
CLFD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLFD
CLFD
OM
OM
Revenue
$34.3M
$28.9M
Net Profit
$-614.0K
$-19.5M
Gross Margin
33.2%
42.4%
Operating Margin
-5.3%
-61.1%
Net Margin
-1.8%
-67.5%
Revenue YoY
-3.2%
-2.0%
Net Profit YoY
67.8%
24.0%
EPS (diluted)
$-0.04
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLFD
CLFD
OM
OM
Q4 25
$34.3M
$28.9M
Q3 25
$23.4M
$29.4M
Q2 25
$49.9M
$31.4M
Q1 25
$47.2M
$29.8M
Q4 24
$29.7M
$29.5M
Q3 24
$5.6M
$28.7M
Q2 24
$48.8M
$27.4M
Q1 24
$36.9M
$28.2M
Net Profit
CLFD
CLFD
OM
OM
Q4 25
$-614.0K
$-19.5M
Q3 25
$-9.1M
$-17.8M
Q2 25
$1.6M
$-18.5M
Q1 25
$1.3M
$-25.8M
Q4 24
$-1.9M
$-25.6M
Q3 24
$-27.9M
Q2 24
$-447.0K
$-34.5M
Q1 24
$-5.9M
$-39.9M
Gross Margin
CLFD
CLFD
OM
OM
Q4 25
33.2%
42.4%
Q3 25
53.2%
39.4%
Q2 25
30.5%
37.8%
Q1 25
30.1%
37.2%
Q4 24
29.2%
36.5%
Q3 24
34.3%
Q2 24
21.9%
35.7%
Q1 24
7.7%
29.2%
Operating Margin
CLFD
CLFD
OM
OM
Q4 25
-5.3%
-61.1%
Q3 25
10.3%
-53.7%
Q2 25
3.0%
-53.7%
Q1 25
0.6%
-55.1%
Q4 24
-6.9%
-74.2%
Q3 24
-83.2%
Q2 24
-4.7%
-112.3%
Q1 24
-26.4%
-131.0%
Net Margin
CLFD
CLFD
OM
OM
Q4 25
-1.8%
-67.5%
Q3 25
-38.8%
-60.6%
Q2 25
3.2%
-59.0%
Q1 25
2.8%
-86.7%
Q4 24
-6.4%
-87.0%
Q3 24
-97.5%
Q2 24
-0.9%
-125.8%
Q1 24
-16.0%
-141.8%
EPS (diluted)
CLFD
CLFD
OM
OM
Q4 25
$-0.04
$0.33
Q3 25
$-0.65
$-1.00
Q2 25
$0.11
$-1.04
Q1 25
$0.09
$-3.66
Q4 24
$-0.13
$-7.21
Q3 24
$-8.02
Q2 24
$-0.04
$-9.96
Q1 24
$-0.40
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLFD
CLFD
OM
OM
Cash + ST InvestmentsLiquidity on hand
$96.4M
$168.9M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$249.7M
$127.0M
Total Assets
$268.1M
$264.5M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLFD
CLFD
OM
OM
Q4 25
$96.4M
$168.9M
Q3 25
$106.0M
$178.6M
Q2 25
$117.2M
$184.1M
Q1 25
$112.0M
$189.0M
Q4 24
$113.0M
$158.7M
Q3 24
$129.0M
$175.6M
Q2 24
$123.8M
$194.8M
Q1 24
$142.9M
$226.9M
Total Debt
CLFD
CLFD
OM
OM
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
$2.2M
Q2 24
$2.1M
Q1 24
Stockholders' Equity
CLFD
CLFD
OM
OM
Q4 25
$249.7M
$127.0M
Q3 25
$256.2M
$142.4M
Q2 25
$264.5M
$154.8M
Q1 25
$265.9M
$169.9M
Q4 24
$267.4M
$26.8M
Q3 24
$275.8M
$47.8M
Q2 24
$274.6M
$68.6M
Q1 24
$279.2M
$93.2M
Total Assets
CLFD
CLFD
OM
OM
Q4 25
$268.1M
$264.5M
Q3 25
$306.2M
$277.3M
Q2 25
$314.7M
$288.8M
Q1 25
$310.9M
$301.2M
Q4 24
$303.2M
$275.8M
Q3 24
$315.3M
$292.9M
Q2 24
$318.1M
$314.5M
Q1 24
$315.4M
$346.2M
Debt / Equity
CLFD
CLFD
OM
OM
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
0.01×
Q2 24
0.01×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLFD
CLFD
OM
OM
Operating Cash FlowLast quarter
$-1.4M
$-9.5M
Free Cash FlowOCF − Capex
$-2.4M
$-9.7M
FCF MarginFCF / Revenue
-7.1%
-33.7%
Capex IntensityCapex / Revenue
2.9%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLFD
CLFD
OM
OM
Q4 25
$-1.4M
$-9.5M
Q3 25
$-6.3M
Q2 25
$7.9M
$-4.8M
Q1 25
$3.0M
$-25.7M
Q4 24
$7.2M
$-16.5M
Q3 24
$22.2M
$-20.6M
Q2 24
$4.0M
$-33.3M
Q1 24
$-5.7M
$-45.9M
Free Cash Flow
CLFD
CLFD
OM
OM
Q4 25
$-2.4M
$-9.7M
Q3 25
$-6.5M
Q2 25
$7.5M
$-5.1M
Q1 25
$654.0K
$-25.8M
Q4 24
$5.1M
$-16.5M
Q3 24
$18.2M
$-21.0M
Q2 24
$2.8M
$-33.5M
Q1 24
$-7.7M
$-46.3M
FCF Margin
CLFD
CLFD
OM
OM
Q4 25
-7.1%
-33.7%
Q3 25
-22.0%
Q2 25
15.1%
-16.3%
Q1 25
1.4%
-86.7%
Q4 24
17.1%
-56.1%
Q3 24
323.0%
-73.1%
Q2 24
5.8%
-122.2%
Q1 24
-20.8%
-164.3%
Capex Intensity
CLFD
CLFD
OM
OM
Q4 25
2.9%
0.8%
Q3 25
2.0%
0.5%
Q2 25
0.8%
0.9%
Q1 25
5.1%
0.4%
Q4 24
7.0%
0.1%
Q3 24
71.4%
1.4%
Q2 24
2.5%
0.4%
Q1 24
5.3%
1.3%
Cash Conversion
CLFD
CLFD
OM
OM
Q4 25
Q3 25
Q2 25
4.93×
Q1 25
2.30×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLFD
CLFD

Segment breakdown not available.

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons